The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
SPECT/CT replaces standard detector with flat-panel x-ray
August 1st 2008Philips Healthcare put a new twist on SPECT/CT with the unveiling at the SNM meeting in June of a hybrid that incorporates a flat-panel x-ray system in place of the typical multislice CT. The novel combination is attuned specifically to the needs of specialists in nuclear medicine, said Jay Mazelsky, senior vice president and general manager of Philips nuclear medicine.
MDS files $1.6 billion suit over abandoned Mo-99 reactors
July 9th 2008MDS has filed a $1.6 billion breach of contract lawsuit against Atomic Energy of Canada Ltd. and the Canadian government for their decision in May to halt development of a twin nuclear reactor complex designed to provide a long-term supply of molybdenum-99, to be refined and distributed by MDS.
Study finds huge variations in pediatric nuclear medicine dosing
July 2nd 2008A survey of children’s imaging services has found a twofold variation in radiopharmaceutical doses administered during pediatric nuclear medicine exams. For some radiopharmaceuticals, the reported maximum activities varied by as much as a factor of 10, and minimum activities differed by as much as a factor of 20, suggesting the need for a consensus among nuclear physicians on appropriate doses for young patients.
Clinical evidence secures reprieve for coronary CTA
July 1st 2008Pending clinical trial results played a pivotal role in the Centers for Medicare and Medicaid Services' decision in March to set aside plans to establish a national payment policy for outpatient multislice coronary CT angiography. Other published trials advanced our understanding of how nuclear cardiology, echocardiography, and cardiac MRI fit in evolving diagnostic practice.
Radiology societies seek Medicare coverage for CT colonography
June 24th 2008Several radiology-related professional societies have joined forces to urge the Centers for Medicare and Medicaid Services to approve national Medicare coverage for CT colonography to screen patients for colorectal cancer.
Report from SNM: Society protests Medicare reimbursement policies
June 18th 2008Society of Nuclear Medicine officials say the Centers for Medicare and Medicaid Services is manipulating the definition of radiopharmaceuticals to artificially deflate its payment rates for radioactive imaging agents essential to nuclear and molecular imaging practice.
Report from SNM: PET avoids unnecessary liver resection for metastatic colon cancer
June 17th 2008Liver resection for metastatic colon cancer is painful and debilitating enough, without a patient’s subsequent discovery that the surgery did nothing to halt disease progression. A multicenter prospective trial presented Monday at the Society of Nuclear Medicine conference in New Orleans found that FDG-PET prevents unnecessary surgeries for one of six patients who undergo liver resection based on CT findings.
Report from SNM: Images of the Year cover molecular imaging from head to toe
June 17th 2008Dr. Henry J. Wagner Jr. has selected two images, a PET/CT scan showing the early metastatic spread of tumor in a patient’s ear and a SPECT/MRI study of osteomyelitis in another patient’s foot, to exemplify the diagnostic capabilities of nuclear medicine as the 2008 Society of Nuclear Medicine Image of the Year.
Report from SNM: PET/CT restaging alters management for one-third of breast cancer cases
June 16th 2008FDG-PET/CT is gaining attention for its role in staging and restaging breast cancer. A trial from the Technical University of Munich, presented Sunday at the 2008 Society of Nuclear Medicine meeting in New Orleans, found that PET/CT detected local or distant recurrence in 67% of breast cancer patients and changed the management plan in 33% of the cases.
Fear of nuclear terrorism lurks behind molybdenum supply debate
June 3rd 2008The crash of the radioisotope supply last winter gets a close look in this month's cover story. It details the politics and policy issues that closed down the Chalk River reactor in Ontario for nearly a month, leaving North American nuclear medicine physicians without a reliable supply of technetium-99.
Isotope supply crash drives push for new moly sources
June 3rd 2008Knowledgeable Canadians considered the molybdenum-99 crisis of 2007 a national disgrace. A squabble between the Canadian Nuclear Safety Commission and Atomic Energy Canada, the federal corporation that owns and operates nuclear research facilities at Chalk River, ON, forced the National Research Universal reactor there to shut down. That action triggered a crisis that cut off production of molybdenum-99, the isotope that produces technetium-99m for thousands of health facilities across Canada and the U.S.
Canadian agency pulls plug on molybdenum reactors
May 19th 2008Atomic Energy Canada has halted development work on twin reactors at Chalk River, ON. They were the planned successors for an aging research nuclear reactor that is the source of molybdenum-99 isotope used in 19 million nuclear medicine imaging procedures annually.
Ground-glass nodules merit scrutiny for differential diagnosis
May 16th 2008Persistent ground-glass nodules in the lungs are worth a closer look, as they are highly associated with malignancy. Dr. Anne Leung offered an overview of how these lesions present on CT imaging at the 2008 Stanford International Symposium on Multidetector-Row CT in Las Vegas.
Flat polyps raise questions in colon cancer screening
May 1st 2008Truly flat or depressed colorectal polyps pose a diagnostic dilemma and are always worth a closer look. A study in the Journal of the American Medical Association may have overstated the case, however, by concluding that these polyps were quite common and carried an increased cancer risk, according to CT colonography experts.
CT colonography experts plan for growing demand
May 1st 2008Academic radiologists who helped invent CT colonography are urging their community-based colleagues to gear up for a possible jump in public demand for CTC following the American Cancer Society's decision in March to add the procedure to its list of preferred colon cancer screening options.